AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

Brain Research

Volumn 1042, Issue 1, 2005, Pages 92-98

  Karasawa, Jun Ichi ^a   Shimazaki, Toshiharu ^a   Kawashima, Naoya ^a   Chaki, Shigeyuki ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

AMPA receptor; Antidepressant; Group II metabotropic glutamate receptor; MGS0039; NBQX; Serotonin

Indexed keywords

2 AMINO 3 (3,4 DICHLOROBENZYLOXY) 6 FLUOROBICYCLO[3.1.0]HEXANE 2,6 DICARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; FLUVOXAMINE; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IMMOBILIZATION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONIN RELEASE; STIMULATION; TASK PERFORMANCE;

EID: 17044396861     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.02.032     Document Type: Article

References (41)

1. F. Bai, X. Li, M. Clay, T. Lindstrom, and P. Skolnick Intra- and interstrain differences in models of "behavioral despair" Pharmacol. Biochem. Behav. 70 2001 187 192
2. F. Bai, M. Bergeron, and D.L.G. Nelson Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus Neuropharmacology 44 2003 1013 1021
3. D. Becqet, M. Faudon, and F. Hery In vivo evidence for an inhibitory glutamatergic control of serotonin release in the cat caudate nucleus: involvement of GABA neurons Brain Res. 519 1990 82 88
4. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 47 2000 351 354
5. D. Bleakman, and D. Lodge Neuropharmacology of AMPA and kainite receptors Neuropharmacology 37 1998 1187 1204
6. K. Borges, and R. Dingledine AMPA receptors: molecular and functional diversity Prog. Brain Res. 116 1998 153 170
7. J. Carlmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptor J. Neurochem. 75 2000 889 907
8. S. Chaki, R. Yoshikawa, S. Hirota, T. Shimazaki, M. Maeda, N. Kawashima, T. Yoshimizu, A. Yasuhara, K. Sakagami, S. Okuyama, S. Nakanishi, and A. Nakazato MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Neuropharmacology 46 2004 457 467
9. E. Chojnacka-Wojcik, A. Klodzinska, and A. Pilc Glutamate receptor ligands as anxiolytics Curr. Opin. Invest. Drugs 2 2001 1112 1119
10. J.T. Coyle, and R.S. Duman Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 38 2003 157 160
11. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245
12. M.J. Detke, M. Rickels, and I. Rucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology 121 1995 66 72
13. D.R. Helton, J.P. Tizzano, J.A. Monn, D.D. Shoepp, and M.J. Kallman Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 284 1998 651 660
14. S. Jordan, G.L. Kramer, P.K. Zukas, M. Moeller, and F. Petty In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine Synapse 18 1994 294 297
15. N. Kawashima, J. Karasawa, T. Shimazaki, S. Chaki, S. Okuyama, A. Yasuhara, A. Nakazato, Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors, Neurosci. Lett. (in press).
16. P.J. Kenny, F. Gasparini, and A. Markou Group II metabotropic and AMPA/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats J. Pharmacol. Exp. Ther. 306 2003 1068 1076
17. J.H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D.S. Charney, G. Marek, C.N. Epperson, A. Goddard, and G.F. Mason Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol. Psychiatry 7 2002 S71 S80
18. X. Li, J.P. Tizzano, K. Griffey, M. Clay, T. Lindstrom, and P. Skolnick Antidepressant-like actions of an AMPA receptor potentiator (LY392098) Neuropharmacology 40 2001 1028 1033
19. M. Mackowiak, M.J. O'Neill, C.A. Hicks, D. Bleakman, and P. Skolnick An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study Neuropharmacology 43 2002 1 10
20. S. Maione, F. Rossi, C.S. Biggs, L.J. Fowler, and P.S. Whitton AMPA receptors modulate extracellular-5-hydroxytryptamine concentration and metabolism in rat striatum in vivo Neurochem. Int. 30 1997 299 304
21. 2A and group II metabotropic glutamate receptor in prefrontal cortex J. Pharmacol. Exp. Ther. 292 2000 76 87
22. R. Martinez-Turrillas, D. Frechilla, and J. Del Rio Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus Neuropharmacology 43 2002 1230 1237
23. R. Martin-Ruiz, M.V. Puig, P. Celada, D.A. Shapiro, B.L. Roth, G. Mengod, and F. Artigas Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptor through glutamate-dependent mechanism J. Neurosci. 15 2001 9856 9866
24. R.I. Melendez, and P.W. Kalivas Metabotropic glutamate receptor regulation of extracellular glutamate levels in the prefrontal cortex Ann. N. Y. Acad. Sci. 1003 2003 443 444
25. 1A autoreceptors Brain Res. 783 1998 173 178
26. M. Papp, and E. Moryl Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression Eur. J. Pharmacol. 263 1994 1 7
27. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates Compact 3rd edition 1997 Academic Press San Diego
28. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions J. Neurochem. 58 1992 1184 1186
29. E. Przegalinski, E. Tatarczynska, A. Deren-Wesotek, and E. Chojnacka-Wojcik Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors Pharmacol. Biochem. Behav. 54 1996 73 77
30. E. Przegalinski, E. Tatarczynska, A. Deren-Wesotek, and E. Chojnacka-Wojcik Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist Neuropharmacology 36 1997 31 37
31. D.D. Schoepp, and P.L. Conn Metabotropic glutamate receptors in brain function and pathology Trends Pharmacol. Sci. 14 1993 13 20
32. M. Shimizu-Sasamata, S. Kawasaki-Yatsugi, M. Okada, S. Sakamoto, S. Yatsugi, J. Togami, K. Hatanaka, J. Ohmori, K. Koshiya, S. Usuda, and K. Murase YM90K: pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainite receptor antagonist J. Pharmacol. Exp. Ther. 276 1996 84 92
33. P. Skolnick Antidepressant for the new millennium Eur. J. Pharmacol. 375 1999 31 40
34. P. Skolnick, B. Legutko, X. Li, and F.P. Bymaster Current perspective on the development of non-biogenic amine-based antidepressants Pharmacol. Res. 43 2001 411 422
35. W.P. Spooren, F. Gasparini, T.E. Salt, and R. Kuhn Novel allosteric antagonists shed light on mglur(5) receptors and CNS disorders Trends Pharmacol. Sci. 22 2001 331 337
36. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
37. C.A. Stewart, and I.C. Reid Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission Mol. Psychiatry 7 2002 S15 S22
38. P. Svenningsson, E.T. Tzavara, J.M. Witkin, A.A. Fienberg, G.G. Nomikos, and P. Greengard Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac) Proc. Natl. Acad. Sci. U. S. A. 99 2002 3182 3187
39. R. Tao, Z. Ma, and S.B. Auerbach Influence of AMPA/kainite receptors on extracellular 5-hydroxytyptamine in rat midbrain raphe and forebrain Br. J. Pharmacol. 121 1997 1707 1715
40. Z.X. Xi, D.A. Baker, H. Shen, D.S. Carson, and P.W. Kalivas Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens J. Pharmacol. Exp. Ther. 300 2002 162 171
41. T. Yoshimizu, and S. Chaki Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039 Biochem. Biophys. Res. Commun. 315 2004 493 496